logo-large
  • Browse Categories

Publications by authors named "Frank Gebhardt"

Claim this Profile
S
Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study.
Beate Schultheis, Dirk Strumberg, Jan Kuhlmann, Martin Wolf, Karin Link, Frank Gebhardt

Cancers (Basel)· October 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase I study of the liposomal RNA interference therapeutic Atu027 in patients with advanced solid tumors.
Beate Schultheis, Dirk Strumberg, Ansgar Santel, Christiane Vank, Frank Gebhardt

J Clin Oncol· December 2014


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.
Graeme M Birdsey, Nicola H Dryden, Valerie Amsellem, Frank Gebhardt, Kapil Sahnan

Blood· April 2008


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GeneBlocs are powerful tools to study and delineate signal transduction processes that regulate cell growth and transformation.
Maria Sternberger, Anett Schmiedeknecht, Anny Kretschmer, Frank Gebhardt, Frauke Leenders

Antisense Nucleic Acid Drug Dev· June 2002


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: